Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-49.99	21.06	42.12
Graham Fair Price	-2.20	7.32	7.49
PEG	9.28	-0.08	0.07
Price/Book	-22.97	0.91	1.18
Price/Cash Flow	12050.95	-3821.46	31.45
Prices/Earnings	-20.09	14.79	-18.50
Price/Sales	-22.76	5.44	7.04
Price/FCF	12050.95	-3821.46	31.45
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.16	0.64	0.64
Operating Margin	101.99	0.26	0.13
ROA	-2.50	< 0.005	< 0.005
ROE	-0.02	0.02	-3.61
ROIC	0.02	0.03	64.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-86.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.17	0.98	466.83
EPS QOQ	-2.67	1.95	-26.88
FCF QOQ	0.04	-1.01	2549.58
Revenue QOQ	< 0.005	-0.02	-215.12
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-7.64	< 0.005	-100.00
Days Sales Outstanding (DSO)	35.16	33.84	-3.75
Inventory Turnover	-11.78	97575000.00	827976702.38
Debt/Capitalization	0.28	0.28	1.25
Quick Ratio	1.92	1.81	-6.04
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.51	12.46	-0.39
Cash	2.78	2.04	-26.72
Capex	-0.02	-0.02	-31.28
Free Cash Flow	0.47	< 0.005	-99.37
Revenue	2.09	2.08	-0.66
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.01	1.96	-2.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.34	4.28	-19.96
Naive Interpretation	Member

06 - Financial Health · Weak

Rating